The demographic shift and the increasing prevalence of chronic wounds represent major challenges for modern health care systems. Classic chronic wounds (venous ulcer, arterial ulcer, mixed ulcer) persist for months or years with a very slow or even no healing progress. Patients suffer from pain and immobility, which dramatically reduces their quality of life. Complications such as infections or tissue necrosis can lead to a bad outcome and amputation of extremities. The Pio device offers a non-invasive and non-toxic therapeutic approach. The system combines the technologies of pulse modulated magnetic fields and light emission locally applied to the wound area. The investigational medical device represents a promising combinational therapeutic approach to synergistically increase the tissues regenerative potential. By stimulating electrophysiological processes at the site of injury, the cells regain its capacity to efficiently regenerate the injured or diseased tissue. It is expected that the patient benefits from a faster healing process, reduced inflammation as well as an improved overall treatment outcome.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
36
The Pio device combines the technologies of pulse modulated magnetic fields and light emission locally applied to the wound area.
Kantonsspital Nidwalden
Stans, Ennetmooserstrasse 19, Switzerland
Venenklinik Bellevue
Kreuzlingen, Switzerland
Spital Männedorf
Zurich, Switzerland
Incidence of adverse event
The incidence of adverse events will be assessed at each visit, prior to the Pio treatment and directly after the Pio treatment. The incidence of treatment-emergent adverse events will be compared to the incidence of standard of care emergent adverse events.
Time frame: At each visit, up to 16 weeks
Severity of adverse event
The severity of adverse events will be assessed at each visit, prior to the Pio treatment and directly after the Pio treatment. The severity of treatment-emergent adverse events will be compared to the severity of standard of care emergent adverse events.
Time frame: At each visit, up to 16 weeks
Time of occurrence of adverse event
The time of occurrence of adverse events will be assessed at each visit, prior to the Pio treatment and directly after the Pio treatment. The time of occurrence of treatment-emergent adverse events will be compared to the time of occurrence of standard of care emergent adverse events.
Time frame: At each visit, up to 16 weeks
Type of adverse event
The type of adverse events will be assessed at each visit, prior to the Pio treatment and directly after the Pio treatment. The type of treatment-emergent adverse events will be compared to the type of standard of care emergent adverse events.
Time frame: At each visit, up to 16 weeks
Wound area
The wound area will be measured weekly right before the Pio treatment.
Time frame: At first visit of the week, before Pio treatment, up to 16 weeks
Wound volume
The wound volume will be measured weekly right before the Pio treatment.
Time frame: At first visit of the week, before Pio treatment, up to 16 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.